# A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)

> **NCT01587235** · PHASE4 · WITHDRAWN · sponsor: **Organon and Co**

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Ezetimibe/simvastatin
- **DRUG:** Other Statin

## Key facts

- **NCT ID:** NCT01587235
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587235, "A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01587235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*